Evidence map›Paper›PMID 37902646›Full record

ArticleBiotechnology and bioengineering2024

Meso- and thermophilic posttreatment of press water coming from a thermophilic municipal solid waste digester.

Eva Maria Prem, Rudolf Markt, Mathias Wunderer, Andreas Otto Wagner

Open access · hybridAbstract read
In one paragraph

Article in Biotechnology and bioengineering, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Eva Maria PremDepartment of Microbiology, Universität Innsbruck, Innsbruck, Austria.ORCID 0000-0003-1734-657X
Rudolf MarktDepartment of Microbiology, Universität Innsbruck, Innsbruck, Austria.ORCID 0000-0003-0195-1249
Mathias WundererDepartment of Microbiology, Universität Innsbruck, Innsbruck, Austria.ORCID 0000-0001-8914-1907
Andreas Otto WagnerDepartment of Microbiology, Universität Innsbruck, Innsbruck, Austria.ORCID 0000-0002-6009-8498
Universität Innsbruck · AT

Funding

Austrian Science Fund FWF P 29143Austrian Science Fund FWF P 29360Austrian Science Fund Phenylomicrobe
6 · The paper itself

Abstract

An efficient biogas production out of organic (waste) materials is important to contribute to a carbon-neutral future. In this study, thermophilic press water (PW) coming from an organic fraction of the municipal solid waste digester was further digested in a thermo- and mesophilic posttreatment approach using two semicontinuous 14 L digesters. The results showed that the PW can still have considerable high biogas potential-at least during the touristic high season in central Europe. The change in temperature led to an increase in volatile fatty acid concentrations and a decrease in biogas production in the mesophilic approach in the first days. However, the losses in biogas production at the beginning could be compensated thus there were no considerable differences in biogas production between thermo- and mesophilic posttreatment at the end of incubation. This can most probably be contributed to a change in the microbial community, and potentially problematic intermediates like valerate could be better degraded in the mesophilic reactor. Especially the abundance of representatives of the phylum Bacteroidota, like Fermentimonas spp., increased during mesophilic anaerobic digestion.

Indexed as

MicrobiotaSolid WasteAnaerobiosisBiofuelsBioreactorsMethaneTemperatureBiofuelsMethaneSolid Wasteamplicon sequencinganaerobic digestionbiogas microbiologytemperature

Identifiers

PMID37902646
PMCPMC10953027
OpenAlexW4388014859

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.